Global Single Cell RNA Sequencing Solution Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Published on: 2024-01-04 | No of Pages : 400 | Industry : Medical
Publisher : MRA | Format : PDF
Global Single Cell RNA Sequencing Solution Market Report, History and Forecast 2018-2034, Breakdown Data by Companies, Key Regions, Types and Application
Single-cell RNA sequencing (scRNA-seq) is a cutting-edge technology that allows researchers to analyze the gene expression profiles of individual cells within a tissue or sample. The scRNA-seq solution comprises a combination of laboratory protocols, sequencing platforms, and computational tools specifically designed for the analysis of single-cell transcriptomes.
Single Cell RNA Sequencing Solution report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Single Cell RNA Sequencing Solution market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Research Institutions and Bioscience Companies are the major drivers for the industry.
The global market for single-cell RNA sequencing solutions has been experiencing significant growth in recent years. The adoption of scRNA-seq technology has revolutionized the field of genomics and biomedical research, allowing researchers to gain unprecedented insights into cellular heterogeneity and gene expression at the single-cell level. The continuous advancements in genomic research and the growing need for in-depth analysis of individual cells have driven the demand for scRNA-seq solutions. scRNA-seq has found applications in various fields, including cancer research, immunology, neuroscience, stem cell research, and precision medicine, further contributing to its market growth. The global market for single-cell RNA sequencing solutions is expected to continue its rapid growth in the coming years. Advancements in technology, improvements in data analysis tools, and the declining costs of sequencing are likely to drive wider adoption across research institutions and industries. Additionally, the application of scRNA-seq in clinical settings and its potential integration with other omics technologies may further expand its market reach.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Single Cell RNA Sequencing Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
TAKARA BIO
BioCat GmbH
Thermo Fisher Scientific
Roche Holding AG
PerkinElmer
Dolomite Bio
Illumina
Witec AG
10x Genomics, Inc
Oxford Nanopore Technologies
QIAGEN
LC Sciences
Pacific Biosciences
Scipio bioscience
CD Genomics
Segment by Type
Equipment
Service
Software
Research Institutions
Bioscience Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Single Cell RNA Sequencing Solution market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Single Cell RNA Sequencing Solution introduction, etc. Single Cell RNA Sequencing Solution Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Single Cell RNA Sequencing Solution market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.
Single Cell RNA Sequencing Solution report published by MRAResearch reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Single Cell RNA Sequencing Solution market is projected to reach US$ million in 2033, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2033. Demand from Research Institutions and Bioscience Companies are the major drivers for the industry.
The global market for single-cell RNA sequencing solutions has been experiencing significant growth in recent years. The adoption of scRNA-seq technology has revolutionized the field of genomics and biomedical research, allowing researchers to gain unprecedented insights into cellular heterogeneity and gene expression at the single-cell level. The continuous advancements in genomic research and the growing need for in-depth analysis of individual cells have driven the demand for scRNA-seq solutions. scRNA-seq has found applications in various fields, including cancer research, immunology, neuroscience, stem cell research, and precision medicine, further contributing to its market growth. The global market for single-cell RNA sequencing solutions is expected to continue its rapid growth in the coming years. Advancements in technology, improvements in data analysis tools, and the declining costs of sequencing are likely to drive wider adoption across research institutions and industries. Additionally, the application of scRNA-seq in clinical settings and its potential integration with other omics technologies may further expand its market reach.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2033), aims to help readers to get a comprehensive understanding of global Single Cell RNA Sequencing Solution market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Companies, Type, Application and Regions Listed in the Report
By Company
TAKARA BIO
BioCat GmbH
Thermo Fisher Scientific
Roche Holding AG
PerkinElmer
Dolomite Bio
Illumina
Witec AG
10x Genomics, Inc
Oxford Nanopore Technologies
QIAGEN
LC Sciences
Pacific Biosciences
Scipio bioscience
CD Genomics
Segment by Type
Equipment
Service
Software
Segment by Application
Research Institutions
Bioscience Companies
Others
By Region
North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Latin America
Mexico
Brazil
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Single Cell RNA Sequencing Solution market further
Chapter 1Global and regional market size and CAGR for the history and forecast period (2018-2023, 2024-2033).
Chapter 2Product Types and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 3Product Application and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2023.
Chapter 4Company Competition Status, Detailed analysis of Product Name companies’ competitive landscape, revenue, market share and ranking, latest development plan, merger, and acquisition information, etc.
Chapter 5Companies’ Outline, covering company’s basic information, Single Cell RNA Sequencing Solution introduction, etc. Single Cell RNA Sequencing Solution Revenue and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 6 to 10Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa by revenue.
Chapter 11Market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry.
Chapter 12MRAResearch’s Conclusions of Single Cell RNA Sequencing Solution market based on comprehensive survey.
Chapter 13Methodology and Data Sources adopted by MRAResearch.